Navigation Links
Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
Date:10/18/2011

PARSIPPANY, N.J., Oct. 18, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) today announced that new data discussing the pharmacoeconomic impact of EXPAREL™ (bupivacaine liposome extended-release injectable suspension), the company's lead investigational product for postsurgical pain management, will be presented during a podium presentation at the American College of Surgeons (ACS) 97th Annual Clinical Congress in San Francisco on Wednesday, October 26. Another podium presentation highlighting the pain control properties and related impact on opioid use of EXPAREL compared to bupivacaine HCl across three surgical models will be presented on Monday, October 24.

Currently under review with the U.S. Food and Drug Administration, EXPAREL is an innovative, long-acting bupivacaine that has been evaluated in multiple Phase 2 and Phase 3 clinical studies to assess prolonged postsurgical analgesia for up to 72 hours with a single-dose local administration into the surgical site. The drug combines bupivacaine with DepoFoam®, Pacira's proven product delivery technology that delivers medication over a desired time period.

The schedule for Pacira podium presentations are as follows:

Presentation Title: Comparison of Immediate-Release Bupivacaine vs. EXPAREL™ (Bupivacaine Extended-Release Liposome Injection) on Opioid Requirements and Related Adverse Events from Phase 2 and 3 Studies Utilizing Multimodal Analgesia Across Multiple Surgical Models

Presented by: Sonia Ramamoorthy, M.D., associate professor of surgery at the University of California, San Diego

Date & Time: Monday, October 24 from 9:45-11:15 a.m. PDT

Location: Moscone Convention Center, Moscone West, 3rd Floor, Room 3014/3016/3018

Presentation Title: EXPAREL™ (Bupivacaine
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
2. Pacira Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference
3. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
4. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
5. Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
6. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
7. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
8. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
9. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
10. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
11. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)...  Mark Farrah Associates (MFA), www.markfarrah.com , ... the 2015 marketplace exchange projections and insights about ... According to a recent ASPE (Office of the ... Health and Human Services) report, an estimated 6.7 ... through the Marketplace as of October 2014 and ...
(Date:12/22/2014)... Dec. 22, 2014 TWi Biotechnology, Inc., ... Allowance for AC-201, TWi Biotechnology,s lead drug candidate, ... China for patent application numbered ... acceptable salts, active metabolite for treatment of type ... of treatment using AC-201 for type II diabetes, ...
(Date:12/19/2014)... 2014 You,re visiting the dentist for what ... he or she says you need a root canal. ... may have several questions and feel apprehensive about your ... it,s nothing to worry about. The Pennsylvania Dental Association ... any anxiety the public may have surrounding this common ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3Root Canals Have Become More Routine 2
... Inc. announced today that it has entered into ... to provide Otsuka with access to BioWa,s POTELLIGENT® ... of their antibody therapeutics with enhanced antibody-dependent cellular ... License was initiated in May, 2007 with Takeda ...
... PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT ... Technologies business at Medtronic exclusive rights for global distribution ... Adenoid) tissue dissection device for the ear, nose, and ... is a major step toward our goal of capturing ...
Cached Medicine Technology:BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 3
(Date:12/22/2014)... (PRWEB) December 22, 2014 The MedTech industry ... Inc, a wholly owned subsidiary of PartnerTech AB of Sweden, ... having recently achieved additional ISO Certification. , All signs point ... employment and the likelihood of a repeal of the excise ... . The industry is anticipating annual growth of 9.3% and ...
(Date:12/22/2014)... December 22, 2014 7,178 small business ... of Black Friday shopping and opted instead to join ... education company, for their 5th annual “Black Friday Boot ... just $7 to attend the 5 hour online training ... promptly donated to support two Central Texas based charities ...
(Date:12/22/2014)... Christmas is days away, and last minute gifts ... solution that will please: the Sublime Gift Card . ... $25 up to $350," says Kathy Heshelow, founder of ... wide array of skin care products and Skin Brushes." , ... , Gift delivery past shipping deadlines, or those last ...
(Date:12/22/2014)... OAK BROOK, Ill. (PRWEB) December 21, 2014 ... receive radiologist recommendations for chest computed tomography (CT) ... have clinically relevant findings, including cancer, according to ... Radiology. , Researchers said the findings show ... chest X-rays represent valuable contributions to patient care. ...
(Date:12/22/2014)... December 22, 2014 Parker & Sons, ... best in Arizona home contracting services reports a record ... its quality services in 2014. As a company that ... early 1970s, Parker and Sons is a business that ... company works side-by-side with other top quality companies in ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
... 18 Taking Control of Your Diabetes,(TCOYD) announced ... national,research firm Yankelovich that found that more than ... think that excess weight has a positive effect ... overweight often contributes,to the development of diabetes, complicates ...
... Cross asks you to help save lives by donating ... is being held on Saturday, February 21, 2009 from ... Koerner of Sewell, New Jersey. To make an ... (1-800-448-3543). (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO )Koerner is battling a ...
... contest for children K-5TULSA, Okla., Feb. 18 There ... sixth annual Be Smart--Don,t Start! storyboard contest, ... of tobacco use. Request free contest materials and information ... be postmarked by Feb. 27.Sponsored by the American Lung ...
... 2009 Takeda Pharmaceutical Company Limited and its wholly-owned ... the United States Food and Drug Administration (FDA) has ... the chronic management of hyperuricemia in patients with gout. ... option in more than 40 years for the more ...
... the journal Nature Genetics have for the ... heart attack and coronary heart disease. In one of ... kind, the Myocardial Infarction Genetics Consortium identified nine precise ... three of them newly discovered; the investigators said that ...
... to be an international leader in personalized medicine and ... of Canadians and to reap the benefits of job ... http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian ... based on an individual,s genetic and health needs, rather ...
Cached Medicine News:Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 3Health News:Blood Drive Held in Honor of Sewell, NJ Resident - Ellie Koerner 2Health News:Last Chance! Be Smart--Don't Start! Entries Due by Feb. 27 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 3Health News:New genomic markers associated with risk of heart disease and early heart attack 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: